Severe Irritant Contact Dermatitis Causing Skin Ulceration Secondary to a Testosterone Patch [PDF]
The Scientific World Journal, 2009 Testosterone replacement has undergone somewhat of a revolution in the past decade with the introduction of topical administration techniques, including patches and gels, as well as an increasing interest in the treatment of older men with low ...
Nathan Lawrentschuk, Neil Fleshner
doaj +8 more sources
Testosterone and the dark ventral patch of male red deer: the role of the social environment [PDF]
The Science of Nature, 2020 The expression of male sexual traits, which is stimulated by testosterone, entails significant costs for individuals. Consequently, natural selection is expected to favour the modulation of sexual trait development according to the balance between its costs and benefits.
Eva de la Peña +3 more
semanticscholar +6 more sources
FDA panel rejects testosterone patch for women on safety grounds [PDF]
BMJ, 2004 A panel of advisers to the US Food and Drug Administration last week unanimously rejected an experimental testosterone patch as a treatment for women with sexual difficulties. Procter & Gamble, global manufacturer of household products, wants to market the patch to women who have become menopausal after ovarian surgery, are currently taking oestrogen,
Ray Moynihan
semanticscholar +4 more sources
Testosterone Patch Increases Sexual Activity and Desire in Surgically Menopausal Women with Hypoactive Sexual Desire Disorder [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2005 AbstractContext: Hypoactive sexual desire disorder (HSDD) is one of the most common sexual problems reported by women, but few studies have been conducted to evaluate treatments for this condition.Objective: The objective of this study was to evaluate the efficacy and safety of a testosterone patch in surgically menopausal women with HSDD.Design: The ...
James A. Simon +12 more
semanticscholar +4 more sources
Contact allergy to a testosterone patch [PDF]
Contact Dermatitis, 1998 D.A. Buckley +2 more
semanticscholar +5 more sources
Open-Label Pilot Study of Testosterone Patch Therapy in Men With Opioid-Induced Androgen Deficiency
The Journal of Pain, 2006 We conducted a 24-week open-label pilot study of testosterone (T) patch therapy in 23 men with opioid-induced androgen deficiency (OPIAD). The T dosage was 5 mg/day for the first 12 weeks and 7.5 mg/day for the second 12 weeks. Seven subjects discontinued prematurely: 4 for noncompliance, 2 for skin irritation and 1 for hepatitis C treatment.
Henry Daniell +2 more
semanticscholar +5 more sources
The Journal of Sexual Medicine, 2005 ABSTRACT Aim To assess the amount of testosterone transferred from the abdominal application sites of a transdermal testosterone patch and a transdermal testosterone gel to cotton T-shirts worn for 24 hours during each treatment. Methods
Norman A. Mazer +5 more
semanticscholar +5 more sources
A Comparison of a Novel Testosterone Bioadhesive Buccal System, Striant, with a Testosterone Adhesive Patch in Hypogonadal Males [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2004 A novel delivery system has been developed for testosterone replacement. This formulation, COL-1621 (Striant), a testosterone-containing buccal mucoadhesive system, has been shown in preliminary studies to replace testosterone at physiological levels when used twice daily.
Márta Korbonits +8 more
openalex +5 more sources
The Role of Transdermal Testosterone Patch Over Pregnancy Rates in Poor Ovarian Responders Undergoing ICSI Cycles [PDF]
The Egyptian Journal of Hospital Medicine, 2019 Background: poor responder management in IVF represents a critical dispute for fertility specialists. Meanwhile, there is a lack of evidence to support the use of any particular intervention to improve treatment outcomes in poor responders because of the
Hassan FI +3 more
openalex +2 more sources
Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus [PDF]
Rheumatology, 2007 Androgen deficiency has been associated with the development of systemic lupus erythematosus (SLE). The aim of this study was to test the efficacy of testosterone patches vs placebo in female SLE patients with baseline mild-to-moderate disease activity in a randomized, double-blind, single-centre placebo-controlled trial.Patients received testosterone (
Caroline Gordon +6 more
openalex +4 more sources